Tsp Capital Management Group, LLC Novavax Inc Transaction History

Tsp Capital Management Group, LLC

$292 Million
Q3 2024

A detailed history of Tsp Capital Management Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 1,350,865 shares of NVAX stock, worth $11.8 Million. This represents 5.85% of its overall portfolio holdings.

Number of Shares

1,350,865

Previous 1,377,125 1.91%

Holding current value

$11.8 Million

Previous $17.4 Million 2.14%

% of portfolio

5.85%

Previous 6.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$10.71 - $17.11 $281,244 - $449,308	-26,260 Reduced 1.91%	1,350,865 $17.1 Million
Q2 2024 Jul 23, 2024	BUY	$3.89 - $20.97 $680 - $3,669	175 Added 0.01%	1,377,125 $17.4 Million
Q1 2024 Apr 30, 2024	BUY	$3.76 - $6.02 $997,340 - $1.6 Million	265,250 Added 23.86%	1,376,950 $6.58 Million
Q4 2023 Jan 16, 2024	BUY	$4.8 - $7.67 $697,680 - $1.11 Million	145,350 Added 15.04%	1,111,700 $5.34 Million
Q3 2023 Nov 07, 2023	BUY	$6.81 - $9.74 $4.08 Million - $5.83 Million	598,600 Added 162.77%	966,350 $7 Million
Q2 2023 Jul 19, 2023	BUY	$6.67 - $9.52 $867,100 - $1.24 Million	130,000 Added 54.68%	367,750 $2.73 Million
Q1 2023 Apr 13, 2023	BUY	$5.76 - $12.48 $1.28 Million - $2.77 Million	221,725 Added 1383.62%	237,750 $1.65 Million
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $34,865 - $71,450	-500 Reduced 3.03%	16,025 $1.18 Million
Q4 2021 Jan 26, 2022	SELL	$134.56 - $217.97 $269,120 - $435,940	-2,000 Reduced 10.8%	16,525 $2.36 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $605,000 - $1.29 Million	-5,000 Reduced 21.25%	18,525 $3.93 Million
Q1 2021 Apr 16, 2021	SELL	$112.98 - $319.93 $3 Million - $8.49 Million	-26,550 Reduced 53.02%	23,525 $4.27 Million
Q4 2020 Feb 03, 2021	SELL	$78.74 - $139.5 $787,400 - $1.4 Million	-10,000 Reduced 16.65%	50,075 $5.58 Million
Q3 2020 Oct 14, 2020	SELL	$79.44 - $178.51 $993,000 - $2.23 Million	-12,500 Reduced 17.22%	60,075 $6.51 Million
Q2 2020 Jul 22, 2020	SELL	$13.86 - $83.61 $937,975 - $5.66 Million	-67,675 Reduced 48.25%	72,575 $6.05 Million
Q1 2020 Apr 23, 2020	BUY	$3.93 - $16.0 $59,932 - $244,000	15,250 Added 12.2%	140,250 $1.91 Million
Q4 2019 Jan 17, 2020	BUY	$3.69 - $5.22 $461,250 - $652,500	125,000 New	125,000 $498,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsp Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsp Capital Management Group, LLC with notifications on news.

Account

Tsp Capital Management Group, LLC Novavax Inc Transaction History